Prophylactic platelet transfusions in patients with blood malignancies: Cost analysis of a randomized trial

Prophylactic platelet transfusions in patients with blood malignancies: Cost analysis of a randomized trial

Show other versions (1)

Background This cost analysis uses data from a randomized trial comparing a no prophylaxis versus prophylactic platelet (PLT) transfusion policy (counts <10 × 109/L) in adult patients with hematologic malignancies.

Manylion Llyfryddiaeth
Prif Awduron:	Campbell, H, Estcourt, L, Stokes, E, Llewelyn, C, Murphy, M, Wood, E, Stanworth, S
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	Blackwell Publishing Inc. 2014

Eitemau Tebyg

Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial.
gan: Campbell, H, et al.
Cyhoeddwyd: (2014)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.
gan: Stanworth, S, et al.
Cyhoeddwyd: (2014)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: A subgroup analysis of a randomized trial (CME)
gan: Stanworth, S, et al.
Cyhoeddwyd: (2014)

Prophylactic platelet transfusions
gan: Estcourt, L, et al.
Cyhoeddwyd: (2010)

Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions.
gan: Stanworth, S, et al.
Cyhoeddwyd: (2010)

Prophylactic platelet transfusions in patients with haematological malignancies – lessons from the TOPPS trial
gan: Estcourt, L
Cyhoeddwyd: (2016)

Platelet transfusions for patients with haematological malignancies: who needs them?
gan: Estcourt, L, et al.
Cyhoeddwyd: (2011)

Alternatives to prophylactic platelet transfusions
gan: Estcourt, L
Cyhoeddwyd: (2016)

Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation
gan: Desborough, M, et al.
Cyhoeddwyd: (2016)

Different platelet count thresholds to guide use of prophylactic platelet transfusions for patients with hematological disorders after myelosuppressive chemotherapy or stem cell transplantation
gan: Estcourt, L, et al.
Cyhoeddwyd: (2016)

Risk of bleeding and use of platelet transfusions in patients with hematological malignancies: recurrent event analysis
gan: Stanworth, S, et al.
Cyhoeddwyd: (2015)

Platelet transfusions in patients with hypoproliferative thrombocytopenia: conclusions from clinical trials and current controversies
gan: Crighton, G, et al.
Cyhoeddwyd: (2016)

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
gan: Estcourt, L, et al.
Cyhoeddwyd: (2012)

The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions.
gan: Estcourt, L, et al.
Cyhoeddwyd: (2013)

The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions
gan: Estcourt, L, et al.
Cyhoeddwyd: (2013)

The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions
gan: Estcourt, L, et al.
Cyhoeddwyd: (2013)

An update on indications for platelet transfusion
gan: Wood, E, et al.
Cyhoeddwyd: (2016)

Prophylactic platelet transfusions.
gan: Pietersz, R, et al.
Cyhoeddwyd: (2012)

Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation
gan: Estcourt, L, et al.
Cyhoeddwyd: (2014)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
gan: Estcourt, L, et al.
Cyhoeddwyd: (2014)

Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
gan: Stanworth, S, et al.
Cyhoeddwyd: (2004)

Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
gan: Stanworth, S, et al.
Cyhoeddwyd: (2004)

Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
gan: Estcourt, L, et al.
Cyhoeddwyd: (2015)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Review)
gan: Estcourt, L, et al.
Cyhoeddwyd: (2015)

Alternatives to allogeneic platelet transfusion
gan: Desborough, M, et al.
Cyhoeddwyd: (2016)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol).
gan: Estcourt, L, et al.
Cyhoeddwyd: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
gan: Estcourt, L, et al.
Cyhoeddwyd: (2014)

Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis
gan: Simon J. Stanworth, et al.
Cyhoeddwyd: (2015-06-01)

Prophylactic platelet transfusions prior to surgery for people with a low platelet count
gan: Estcourt, L, et al.
Cyhoeddwyd: (2017)

Prophylactic platelet transfusions prior to surgery for people with a low platelet count
gan: Estcourt, L, et al.
Cyhoeddwyd: (2018)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
gan: Crighton, GL, et al.
Cyhoeddwyd: (2015)

Prophylactic platelet transfusions in critical care – how low can you go?
gan: Shah, A, et al.
Cyhoeddwyd: (2023)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Russian Translation of Cochrane Plain Language Summary)
gan: Crighton, GL, et al.
Cyhoeddwyd: (2021)

Guidelines for the use of platelet transfusions
gan: Estcourt, L, et al.
Cyhoeddwyd: (2016)

Prophylactic plasma transfusion for patients undergoing non-cardiac surgery
gan: Huber, J, et al.
Cyhoeddwyd: (2017)

Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review
gan: Desborough, M, et al.
Cyhoeddwyd: (2016)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
gan: Estcourt, L, et al.
Cyhoeddwyd: (2014)

Platelet transfusion thresholds in premature neonates (PlaNeT-2 trial)
gan: Estcourt, LJ
Cyhoeddwyd: (2019)

A no-prophylaxis platelet-transfusion strategy for hematologic cancers.
gan: Stanworth, S, et al.
Cyhoeddwyd: (2013)

Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia
gan: Estcourt, L, et al.
Cyhoeddwyd: (2015)